Immune Pharma (IMNP) Shares Higher Amid AmiKet Development News, Capital Investment

September 16, 2016 7:59 AM EDT
Get Alerts IMNP Hot Sheet
Trade IMNP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Immune Pharma (NASDAQ: IMNP) shares are up over 11 percent in early trading following news that the company designated a subsidary to develop AmiKet and also received a $20 infusion. For more color, click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk

Add Your Comment